✦ LIBER ✦

Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy

✍ Scribed by Alfred M. Cohen; Nancy Schaeffer; Joy Higgins

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 372 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860315)57:6<1115::aid-cncr2820570609>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Superselective intra-arterial chemothera

Superselective intra-arterial chemotherapy with mitomycin C in hepatic metastases from colorectal cancer

✍ Mäkelä, Jyrki; Kantola, Riitta; Tikkakoski, Tapani; Siniluoto, Topi; Leinonen, S 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

Background: Mitomycin C has been found clinically useful in the treatment of colorectal cancer when administered via the hepatic artery. In a prospective therapeutic trial, we studied the effect of superselective intraarterial chemotherapy with mitomycin C in patients with hepatic metastases from co

Combination chemotherapy of metastatic b

Combination chemotherapy of metastatic breast cancer with vincristine, adriamycin and prednisolone

✍ J. A. Russell; J. W. Baker; P. J. Dady; H. T. Ford; J. C. Gazet; J. A. McKinna; 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 1 views

Results of pharmacokinetic modulating ch

Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases

✍ Masato Kusunoki; Hidenori Yanagi; Masafumi Noda; Reigetsu Yoshikawa; Takehira Ya 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## BACKGROUND. Pharmacokinetic modulating chemotherapy (PMC) is a new therapeutic concept in combination with continuous 5-fluorouracil (5-FU) infusion and UFT. UFT enhanced plasma 5-FU concentration and antitumor effects during 5-FU infusion. The authors report on their experiences with arterial

Treatment of metastatic breast cancer wi

Treatment of metastatic breast cancer with a combination of adrenalectomy and 5-fluorouracil Progress report

✍ Richard E. Wilson; Anthony J. Piro; Menelaos A. Aliapoulios; Francis D. Moore 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 2 views

Experience with continuous regional chem

Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study

✍ M. Margaret Kemeny; David A. Goldberg; Scott Browning; Gerald E. Metter; Paula J 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 1 views

Sixty-five patients with hepatic metastases from colorectal primaries were studied in a prospective randomized fashion. The five patients with solitary metastases all had resection of metastases and 50% were randomized to pump therapy. Of the 16 patients with multiple resectable metastases, 7 had pu

A multicenter evaluation of intensified,

A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma

✍ Francis Lévi; Rachid Zidani; Silvano Brienza; Luigi Dogliotti; Bruno Perpoint; M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

## BACKGROUND. The combination of 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (l-OHP) was shown to be both more active against metastatic colorectal carcinoma and better tolerated if the drug delivery rate was chronomodulated according to circadian rhythms rather than constant. This all